Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

COVID-19 treatment: Happy that WHO resumed trials of hydroxychloroquine, says CISR

Copy URL
Embed

World Health Organisation (WHO) has resumed trials of hydroxychloroquine (HCQ). Speaking on it, Director General of Council of Scientific an Industrial Research (CSIR), Dr. Shekhar C Mande said, “We are happy that the WHO resumed trials of hydroxychloroquine (HCQ). I firmly believe that the WHO's decision was taken in haste. It was a kind of knee-jerk reaction. They should have analysed the data on their own before temporarily suspending trials.”

Have something to say? Post your comment

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service